Home Cart 0 Sign in  
X

[ CAS No. 2973-80-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 2973-80-0
Chemical Structure| 2973-80-0
Chemical Structure| 2973-80-0
Structure of 2973-80-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2973-80-0 ]

Related Doc. of [ 2973-80-0 ]

Alternatived Products of [ 2973-80-0 ]

Product Details of [ 2973-80-0 ]

CAS No. :2973-80-0 MDL No. :MFCD03033065
Formula : C7H5BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :SCRQAWQJSSKCFN-UHFFFAOYSA-N
M.W : 201.02 Pubchem ID :387179
Synonyms :

Calculated chemistry of [ 2973-80-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.55
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 2.3
Log Po/w (WLOGP) : 1.97
Log Po/w (MLOGP) : 1.55
Log Po/w (SILICOS-IT) : 2.18
Consensus Log Po/w : 1.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.91
Solubility : 0.245 mg/ml ; 0.00122 mol/l
Class : Soluble
Log S (Ali) : -2.72
Solubility : 0.382 mg/ml ; 0.0019 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.63
Solubility : 0.473 mg/ml ; 0.00236 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.09

Safety of [ 2973-80-0 ]

Signal Word:Danger Class:9
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P362+P364-P403+P233-P501 UN#:3077
Hazard Statements:H315-H318-H335-H411 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2973-80-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2973-80-0 ]
  • Downstream synthetic route of [ 2973-80-0 ]

[ 2973-80-0 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 2973-80-0 ]
  • [ 62803-47-8 ]
Reference: [1] Chemical Communications, 2011, vol. 47, # 23, p. 6635 - 6637
  • 2
  • [ 2973-80-0 ]
  • [ 14472-14-1 ]
Reference: [1] Monatshefte fuer Chemie, 1954, vol. 85, p. 802,805
  • 3
  • [ 2973-80-0 ]
  • [ 3964-56-5 ]
Reference: [1] Monatshefte fuer Chemie, 1936, vol. 67, p. 320,322
  • 4
  • [ 2973-80-0 ]
  • [ 3217-15-0 ]
Reference: [1] Monatshefte fuer Chemie, 1936, vol. 67, p. 320,322
  • 5
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
YieldReaction ConditionsOperation in experiment
63% With bromine In dichloromethane at 35 - 40℃; 3-Hydroxybenzaldehyde (120g, 0.98 moles) was suspended in 2400 ML OF CH2CL2 in a 5L 4-neck round bottom flask equipped with overhead stirrer, temperature probe, addition funnel, and condenser. The mixture was heated to 35-40° C in order to dissolve the starting material. Bromine (52 mL, 1.0 moles, 1.02 eq. ) was added dropwise through the addition funnel at a rate which maintained the reaction temperature between 35-38° C. The mixture was then allowed to stir overnight at 35 C. THE mixture was slowly cooled to-5-0° C over two hours and then allowed to stir at that temperature for lh more. The solid which formed was then collected by filtration through a Buchner funnel and the filter cake washed with 400mL of a cold 1 : 1 CHZCHEPTANE solution. The gray solid was then dried in vacuo (0.2mm Hg) at room temperature. Yield = 124.3g (63percent).
55% at 15 - 22℃; Example 1; 2-bromo-5-hydroxybenzaldehyde (3) 3-hydroxybenzaldehyde (10 g, 81.9 mmol) was dissolved in glacial acetic acid (50 mL) and cooled at 15° C. To the stirred solution, bromine (15.7 g, 98.2 mmol) was added dropwise while keeping the temperature below 22° C. After overnight stirring at room temperature, the volatiles were removed under vacuum without heating; the residue was co-evaporated three times with hexane (15 mL) and taken up in warm chloroform. Upon cooling, 9.05 g of 2-bromo-5-hydroxybenzaldehyde 3 were obtained as a white solid in two crops. Yield 55percent.1H NMR (300 MHz, CD3COCD3) δ ppm: 10.24 (s, 1H), 9.05 (s, 1H), 7.58 (d, J=8.7 Hz, 1H), 7.34 (d, J=3.1 Hz, 1H), 7.10 (dd, J1=8.7 Hz, J2=3.1 Hz, 1H); 13C NMR (75 MHz, CD3COCD3) δ ppm: 192.8, 159.3, 136.7, 136.2, 125.1, 117.3, 117.2; HRMS (EI) m/z: calcd for C7H5BrO2: 199.9472, found: 199.9463; mp: 132-134° C.
55% at 20℃; To a stirred solution of 1.5 g (12.3 mmol) of 3-hydroxybenzaldehyde in 10 mL of glacialacetic acid at 22C was added 2.35 g (14.7 mmol) of bromine so as to keep the temperatureat or below 22. After stirring overnight at r.t., the volatiles were removed underreduced pressure. The residue was washed with hexane (3 £ 15 mL) and then taken up inwarm chloroform. After cooling, a total of 1.35 g (55percent) of 2-bromo-5-hydroxybenzaldehyde2 was obtained in two crops. Mp: 132–134C, lit. mp 134 C.27 1H RMN(300 MHz, CD3COCD3) d ppm: 10.24 (s, 1H), 9.05 (s, 1H), 7.58 (d, J D 8.7 Hz, 1H),7.34 (d, J D 3.1 Hz, 1H), 7.10 (dd, J1 D 8.7 Hz, J2 D 3.1 Hz, 1H); 13C RMN (75 MHz,CD3COCD3) d ppm: 192.8 (CHO), 159.3 (C-5), 136.7 (C-6), 136.2 (C-1), 125.1 (C-4),117.3 (C-3), 117.2 (C-2); HRMS (EI) m/z: Calcd for C7H5BrO2: 199.9472. Found:199.9463.
55% With bromine In chloroform; acetonitrile at 20℃; for 4 h; Cooling with ice A suspension of 3-hydroxybenzaldehyde (48.85 g, 400 mmol) in a 10:1 mixture of chloroformlacetonitril (330 mL) was cooled with an ice bath. Then, bromine (63.9 g, 1 equiv) was added dropwise and the bath was removed to stir the mixture at room temperature. After 4 h, the reaction was quenched with a saturated NaHCO3 solution (150 mL). The phases were separated and the organic layer was washed with water (150 mL). The concentrated organic phase was filtered through a thin pad of Celite and eluted with a 4:1 mixture of dichloromethane/ethyl acetate. Solvent was removed in vacuo and the remaining solid was crystallized several times from ethyl acetate/hexane to give 44.15 g of 2-bromo-5- hydroxybenzaldehyde as light brown needles. Yield 55percent; mp: 132-134 °C. ‘H NMR (300 MHz, CD3COCD3) ö ppm: 10.24 (s, 1H), 9.05 (s, 1H), 7.58 (d, J= 8.7 Hz, 1H), 7.34 (d, J= 3.1 Hz, 1H), 7.10 (dd, J, = 8.7 Hz, J2 = 3.1 Hz, 1H); ‘3C NMR (75 MHz, CD3COCD3) ö ppm: 192.8, 159.3, 136.7, 136.2, 125.1, 117.3, 117.2; HRMS (EI)mlz: calcd for C7H5BrO2: 199.9472, found: 199.9463.
50% With bromine; sodium carbonate In chloroform Preparation of 2-bromo-5-hydroxybenzaldehyde:
A solution of 4.2 ml of bromine (82 mmol) in 30 ml of chloroform is slowly added to a solution of 10 g of 3-hydroxybenzaldehyde (82 mmol) in 100 ml of chloroform.
The reaction solution is then combined with 50 ml of 6percent sodium carbonate solution and vigorously stirred.
Once neutralisation is complete, the phases are separated and the solvent removed from the organic phase.
The crude product is recrystallized with dilute acetic acid, whereupon 8.24 g of the product (7) are obtained as white needles at a yield of 50percent.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 8, p. 955 - 959
[2] Patent: US2004/19018, 2004, A1, . Location in patent: Page/Page column Sheet 2
[3] Journal of the Iranian Chemical Society, 2011, vol. 8, # 2, p. 531 - 536
[4] Tetrahedron Letters, 2009, vol. 50, # 9, p. 1007 - 1009
[5] Synthetic Communications, 2007, vol. 37, # 4, p. 581 - 585
[6] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 3, p. 1169 - 1172
[7] Journal of Organic Chemistry, 2002, vol. 67, # 26, p. 9248 - 9256
[8] Journal of Natural Products, 2008, vol. 71, # 11, p. 1938 - 1941
[9] Antimicrobial Agents and Chemotherapy, 2014, vol. 58, # 6, p. 3312 - 3326
[10] Chemical Communications, 2015, vol. 51, # 95, p. 16992 - 16995
[11] Organic Process Research and Development, 2017, vol. 21, # 10, p. 1625 - 1632
[12] Journal of Organic Chemistry, 1999, vol. 64, # 13, p. 4949 - 4952
[13] Acta Crystallographica Section C: Crystal Structure Communications, 2000, vol. 56, # 3, p. 354 - 355
[14] Organic Process Research and Development, 2004, vol. 8, # 5, p. 738 - 743
[15] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 24, p. 6328 - 6333
[16] Patent: WO2004/89890, 2004, A2, . Location in patent: Page 26-27; 32
[17] Organic letters, 2002, vol. 4, # 16, p. 2711 - 2714
[18] Organic Letters, 2018, vol. 20, # 17, p. 5177 - 5180
[19] Patent: US2011/105545, 2011, A1, . Location in patent: Page/Page column 17
[20] Organic Preparations and Procedures International, 2017, vol. 49, # 3, p. 265 - 272
[21] Patent: WO2017/134146, 2017, A1, . Location in patent: Page/Page column 44; 55; 100
[22] Tetrahedron Letters, 2004, vol. 45, # 26, p. 5091 - 5094
[23] Patent: US2002/16513, 2002, A1,
[24] Chemistry - A European Journal, 2016, vol. 22, # 29, p. 10194 - 10202
[25] Journal of Medicinal Chemistry, 1998, vol. 41, # 15, p. 2745 - 2753
[26] Synthesis, 2009, # 12, p. 2040 - 2060
[27] Journal of the Chemical Society, 1925, vol. 127, p. 876,877[28] Journal of the Chemical Society, 1926, p. 150
[29] Chemische Berichte, 1909, vol. 42, p. 4169
[30] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 4, p. 134
[31] Journal of the Indian Chemical Society, 1952, vol. 29, p. 363,364
[32] Journal of the American Chemical Society, 1994, vol. 116, # 18, p. 8392 - 8393
[33] Journal of the Chemical Society, 1925, vol. 127, p. 876,877[34] Journal of the Chemical Society, 1926, p. 150
[35] Patent: WO2013/174848, 2013, A2, . Location in patent: Page/Page column 18
  • 6
  • [ 7507-86-0 ]
  • [ 2973-80-0 ]
YieldReaction ConditionsOperation in experiment
90.9% With boron tribromide In dichloromethane at 0 - 25℃; for 3 h; To a mixture of 2-bromo-5-methoxybenzaldehyde (2000.0 mg, 9.3 mmol) indichioromethane (10 mL) was added boron tribromide (2M in DCM; 4.65 mL, 9.3 mmol) slowly at 0 °C. The reaction was warmed up to 25 °C and stirred for 3 h. The reaction was quenched with water (10 mL) at 0°C and extracted with EtOAc (50 mL). The organic layer was washed with water (50 mL x 2) and brine (50 mL), dried over Mg504 and concentrated. The residue was purified by flash column chromatography (petroleum ether) to afford 2-bromo-5-hydroxybenzaldehyde (1.7 g, 90.9percent yield) as a colorless oil.
Reference: [1] Patent: WO2017/84630, 2017, A1, . Location in patent: Paragraph 00976
[2] Journal of Medicinal Chemistry, 2000, vol. 43, # 4, p. 599 - 608
[3] Patent: WO2005/123668, 2005, A1, . Location in patent: Page/Page column 46
[4] Patent: WO2005/123668, 2005, A1, . Location in patent: Page/Page column 47
  • 7
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 3111-51-1 ]
  • [ 20035-32-9 ]
Reference: [1] Tetrahedron, 2010, vol. 66, # 34, p. 6928 - 6935
  • 8
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 20035-32-9 ]
Reference: [1] Chemistry - A European Journal, 2007, vol. 13, # 30, p. 8543 - 8563
  • 9
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 196081-71-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 26, p. 5091 - 5094
  • 10
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 704-13-2 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 7, p. 831 - 833
  • 11
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 3111-51-1 ]
Reference: [1] Tetrahedron, 2010, vol. 66, # 34, p. 6928 - 6935
  • 12
  • [ 1700-37-4 ]
  • [ 2973-80-0 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1982, vol. 21, # 2, p. 95 - 97
  • 13
  • [ 42454-06-8 ]
  • [ 2973-80-0 ]
Reference: [1] Journal of the Chemical Society, 1925, vol. 127, p. 876,877[2] Journal of the Chemical Society, 1926, p. 150
  • 14
  • [ 2973-80-0 ]
  • [ 74-88-4 ]
  • [ 7507-86-0 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 60 h; To a solution of 2-bromo-5-hydroxybenzaldehyde (1000.0 mg, 4.975 mmol) in DMF (20 mL) were added methyl iodide (0.31 mL, 5.000 mmol) and potassium carbonate (1036.6 mg, 7.500 mmol). The reaction mixture was stirred at rt for 2.5 days. Water was added and the reaction mixture was extracted with hexanes-ether (1:1) solvent system. The combined organic phases were dried over Na2SO4, filtered and concentrated in vacuum to yield 2-bromo-5-methoxybenzaldehyde (1069.8 mg, 100percent) as colorless oil. LC-MS (M+H)+=215.11. 1H NMR (500 MHz, DMSO-d6) δ 10.18 (s, 1H). 7.70 (d, J=10 Hz, 1H) 7.35 (d, J=3 Hz, 1H) 7.23 (dt, J1=7.0 Hz, J2=2.0 Hz, 1H) 3.83 (s, 3H).
Reference: [1] Patent: US2008/194535, 2008, A1, . Location in patent: Page/Page column 30
[2] Organic letters, 2002, vol. 4, # 16, p. 2711 - 2714
[3] Journal of the Chemical Society, 1951, p. 181,184
  • 15
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 704-13-2 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 7, p. 831 - 833
  • 16
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 3111-51-1 ]
  • [ 20035-32-9 ]
Reference: [1] Tetrahedron, 2010, vol. 66, # 34, p. 6928 - 6935
  • 17
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 20035-32-9 ]
Reference: [1] Chemistry - A European Journal, 2007, vol. 13, # 30, p. 8543 - 8563
  • 18
  • [ 2973-80-0 ]
  • [ 75-03-6 ]
  • [ 43192-32-1 ]
Reference: [1] Patent: WO2006/55525, 2006, A2, . Location in patent: Page/Page column 90
[2] Patent: WO2010/129729, 2010, A1, . Location in patent: Page/Page column 52-53
[3] Patent: WO2011/146324, 2011, A1, . Location in patent: Page/Page column 65
[4] Patent: WO2012/24183, 2012, A1, . Location in patent: Page/Page column 120
[5] Patent: EP2842946, 2015, A1, . Location in patent: Paragraph 1516; 1517
  • 19
  • [ 64-67-5 ]
  • [ 2973-80-0 ]
  • [ 43192-32-1 ]
Reference: [1] Journal of Scientific and Industrial Research, 1952, vol. 11 B, p. 35
  • 20
  • [ 100-83-4 ]
  • [ 2973-80-0 ]
  • [ 196081-71-7 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 26, p. 5091 - 5094
  • 21
  • [ 2973-80-0 ]
  • [ 100-39-0 ]
  • [ 85604-06-4 ]
YieldReaction ConditionsOperation in experiment
97% With tetra-(n-butyl)ammonium iodide; potassium carbonate In N,N-dimethyl-formamide at 0 - 20℃; Example 396 : Synthesis of (1E,6E)-1-(5-benzyloxy-2-bromophenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione (CU531); (1) Synthesis of 5-benzyloxy-2-bromobenzaldehyde; To a suspension of 2-bromo-5-hydroxybenzaldehyde (100 mg, 0.50 mmol), potassium carbonate (138 mg, 1.00 mmol), and tetrabutylammonium iodide (18 mg, 0.05 mmol) in 1.0 mL of dry N,N-dimethylformamide was added benzyl bromide (89 μL, 0.74 mmol) at 0°C. After being stirred at room temperature overnight, the reaction mixture was diluted with diethyl ether, and the solution was washed with water, saturated NaHCO3 aqueous solution, brine, and dried over MgSO4. After filtration, the filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate = 95/5 to 80/20) to obtain the title compound as a colorless oil (140 mg, 97percent).
97% With potassium carbonate In N,N-dimethyl-formamide at 0 - 20℃; To a suspension of 2-bromo-5-hydroxybenzaldehyde (100 mg, 0.50 mmol), potassium carbonate (138 mg, 1.00 mmol), and tetrabutylammonium iodide (18 mg, 0.05 mmol) in 1.0 mL of dry N,N-dimethylformamide was added benzyl bromide (89 μL, 0.74 mmol) at 0° C.
After being stirred at room temperature overnight, the reaction mixture was diluted with diethyl ether.
The solution was washed with water, saturated NaHCO3 aqueous solution, brine, and dried over MgSO4.
After filtration, the filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate=95/5 to 80/20) to obtain the title compound as a colorless oil (140 mg, 97percent).
Reference: [1] Bulletin of the Korean Chemical Society, 2010, vol. 31, # 7, p. 2047 - 2050
[2] Patent: EP2123637, 2009, A1, . Location in patent: Page/Page column 110
[3] Patent: US2011/82295, 2011, A1, . Location in patent: Page/Page column 14
[4] Journal of Organic Chemistry, 2016, vol. 81, # 20, p. 10062 - 10070
[5] Journal of Organic Chemistry, 1999, vol. 64, # 13, p. 4949 - 4952
[6] Journal of the American Chemical Society, 1994, vol. 116, # 18, p. 8392 - 8393
[7] Patent: US2007/72833, 2007, A1, . Location in patent: Page/Page column 19
[8] Patent: WO2014/6020, 2014, A1, . Location in patent: Page/Page column 46
[9] Chemistry - A European Journal, 2017, vol. 23, # 62, p. 15775 - 15782
  • 22
  • [ 2973-80-0 ]
  • [ 100-44-7 ]
  • [ 85604-06-4 ]
YieldReaction ConditionsOperation in experiment
96% With potassium carbonate In acetone for 10 h; Reflux 201 g (1 mol) of 2-bromo-5-hydroxybenzaldehyde, 1000 ml of acetone, and 276 g of potassium carbonate (1.1 mol) were added to the reaction vessel, and 152 g (1.2 mol) of benzyl chloride was added thereto with stirring, and the mixture was refluxed for 10 hours to recover a solvent. Add 1000ml water, beaten, filter, reducePress drying to obtain 279 g of solid, yield 96percent;
Reference: [1] Journal of Natural Products, 2008, vol. 71, # 11, p. 1938 - 1941
[2] Patent: CN108530476, 2018, A, . Location in patent: Paragraph 0046; 0090-0091
[3] Tetrahedron, 1992, vol. 48, # 5, p. 913 - 922
[4] Journal of Medicinal Chemistry, 2000, vol. 43, # 4, p. 599 - 608
  • 23
  • [ 2973-80-0 ]
  • [ 906673-45-8 ]
Reference: [1] Patent: WO2018/115362, 2018, A1,
  • 24
  • [ 1194-02-1 ]
  • [ 2973-80-0 ]
  • [ 906673-54-9 ]
YieldReaction ConditionsOperation in experiment
71% With potassium carbonate In N,N-dimethyl-formamide; toluene at 115℃; for 8 h; Inert atmosphere In a round bottom flask, under nitrogen atmosphere, 2-bromo-5-hydroxybenzaldehyde (100 g, 497 mmol) and 4-fluorobenzonitrile (301 .2 g, 2487 mmol) were dissolved in DMF (250 ml) and toluene (500 ml). To the resulting dark solution, potassium carbonate (206.2 g, 1492 mmol) was added and the resulting mixture was stirred for 8 hours at 1 15 °C. After the reaction was completed by TLC, the heterogeneous mixture was filtered. The solvents and 4-fluoro-benzonitrile were distilled under reduced pressure from the obtained filtrate. Ethyl acetate (800 ml), water (500 ml) and brine (40 ml) were added and the formed phases were separated at 65-70 °C. The aqueous phase was extracted with ethyl acetate (150 ml) at 65-70 °C and the combined organic phase was washed with a mixture of water (225 ml) and brine (180 ml) at 65-70 °C. The obtained organic phase was evaporated under reduced pressure to give a brown solid. The solid was purified twice by recrystallization in a hot mixture of ethyl acetate and toluene to give 4-(4-bromo-3- formylphenoxy)benzonitrile (compound A) (107.5 g). Yield: 71 percent Purity by HPLC: >99percent 1H-NMR (200 MHz, CDCI3, δ ppm): 10.32 (1 H, s); 7.62-7.72 (3H, m); 7.57-7.59 (1 H, dd; J= 3, J= 1 ); 7.18- 7.23 (1 H, dd, J=8 Hz, J=3 Hz), 7.01 -7.08 (2H, m) 13C-NMR (50 MHz, CDCI3, δ ppm): 190.69; 160.08; 155.13; 135.59; 134.89; 134.39; 126.86; 121.81 ; 120.28; 1 18.68; 1 18.33; 107.32 DSC: Endothermic peak at 1 1 1.9 °C.
50 g With potassium carbonate In N,N-dimethyl-formamide at 75 - 85℃; for 20 h; A mixture of 2-bromo-5-hydroxybenzaldehyde (50g), 4-fluorobenzonitrile (75.3 lg) and potassium carbonate (103g) in dimethylformamide (500mL) was stirred at about 75°C to about 85°C for about 20h. The reaction mixture was filtered and the filtrate was quenched with water at about room temperature, stirred for about 2h, filtered and dried. The crude product was purified by ethyl acetate. Yield: 50g HPLC purity: >99percent
Reference: [1] Patent: WO2018/115362, 2018, A1, . Location in patent: Paragraph 0120
[2] Patent: US2007/72833, 2007, A1, . Location in patent: Page/Page column 20
[3] Patent: WO2018/224923, 2018, A1, . Location in patent: Paragraph 0167; 0181
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 2973-80-0 ]

Crisaborole Intermediates

Chemical Structure| 906673-54-9

[ 906673-54-9 ]

4-(4-Bromo-3-formylphenoxy)benzonitrile

Related Functional Groups of
[ 2973-80-0 ]

Aryls

Chemical Structure| 22532-60-1

[ 22532-60-1 ]

2-Bromo-4-hydroxybenzaldehyde

Similarity: 0.96

Chemical Structure| 22532-61-2

[ 22532-61-2 ]

2-Bromo-6-hydroxybenzaldehyde

Similarity: 0.94

Chemical Structure| 199177-26-9

[ 199177-26-9 ]

3-Bromo-5-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 1761-61-1

[ 1761-61-1 ]

5-Bromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 43192-31-0

[ 43192-31-0 ]

2-Bromo-4-methoxybenzaldehyde

Similarity: 0.88

Bromides

Chemical Structure| 22532-60-1

[ 22532-60-1 ]

2-Bromo-4-hydroxybenzaldehyde

Similarity: 0.96

Chemical Structure| 22532-61-2

[ 22532-61-2 ]

2-Bromo-6-hydroxybenzaldehyde

Similarity: 0.94

Chemical Structure| 199177-26-9

[ 199177-26-9 ]

3-Bromo-5-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 1761-61-1

[ 1761-61-1 ]

5-Bromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 43192-31-0

[ 43192-31-0 ]

2-Bromo-4-methoxybenzaldehyde

Similarity: 0.88

Aldehydes

Chemical Structure| 22532-60-1

[ 22532-60-1 ]

2-Bromo-4-hydroxybenzaldehyde

Similarity: 0.96

Chemical Structure| 22532-61-2

[ 22532-61-2 ]

2-Bromo-6-hydroxybenzaldehyde

Similarity: 0.94

Chemical Structure| 199177-26-9

[ 199177-26-9 ]

3-Bromo-5-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 1761-61-1

[ 1761-61-1 ]

5-Bromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 43192-31-0

[ 43192-31-0 ]

2-Bromo-4-methoxybenzaldehyde

Similarity: 0.88